Status:
COMPLETED
Cholesterol Reduction in Seniors Program (CRISP)
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Atherosclerosis
Cardiovascular Diseases
Eligibility:
All Genders
65-100 years
Phase:
PHASE2
Brief Summary
To conduct a pilot study to determine whether lowering elevated serum cholesterol levels with 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG CoA) reductase inhibitors reduced mortality due to the sequela...
Detailed Description
BACKGROUND: Circulating levels of cholesterol, specifically cholesterol associated with the low-density lipoprotein (LDL) fraction, have been established by observational epidemiologic studies and by...
Eligibility Criteria
Men and women, ages 65 and older, with elevated low-density lipoprotein cholesterol levels between 159 and 221 mg/dl at entry.
Key Trial Info
Start Date :
July 1 1990
Trial Type :
INTERVENTIONAL
End Date :
June 1 1992
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00000477
Start Date
July 1 1990
End Date
June 1 1992
Last Update
February 18 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.